3 ms·
Or have competition in the form of foreign FDA counterparts. If the European/Japanese/Other Reputable Country authorities have approved a drug, it could be all
by BurningFrog 10y ago
Or have competition in the form of foreign FDA counterparts.
If the European/Japanese/Other Reputable Country authorities have approved a drug, it could be allowed it in the US, with a clear label, of course.
Foreign physiology and science is the same as American.
- throwaway2016a 10y agoTrue. That is a good idea. Why shouldn't I be able to buy drugs that are approved by Canada for instance?
- woofyman 10y agoThalidomide is the poster child for dangerous drugs approved elsewhere but not by the FDA. Experts estimate that the drug thalidomide led to the death of approximately 2,000 children and serious birth defects in more than 10,000 children, about 5,000 of them in West Germany. https://en.m.wikipedia.org/wiki/Thalidomide https://en.m.wikipedia.org/wiki/Thalidomide http://www.thalidomide.ca/the-canadian-tragedy/ http://www.thalidomide.ca/the-canadian-tragedy/
- deleted 10y ago[deleted]
- SapphireSun 10y agoThere are some merits to this idea, but there's a major flaw. It's kind of like tax havens. If you have two countries with different tax rates, all else being equal, a multinational will set up HQ in the lower tax county. Likewise, for pharmaceuticals, the company will pick the country that has the lowest barrier to entry and then sell to both. While within a country a given barrier may be too high or low, it will probably be somewhat randomly too high or low around some appropriate level of safety. With the multi-country scheme, the bias will be towards too low on nearly every drug.